Have a question?
Open from 8am to 7pm Monday to FridayCall customer services
0345 54 32 600

BASILEA N (BSLN)

Sell: 55.20 CHF|Buy: 55.00 CHF|Change: 0.70 (1.28%)

This share can be held in a Dealing account Stocks and shares ISA Lifetime ISA JISA SIPP

Company profile

Basilea Pharmaceutica Ltd is a commercial-stage biopharmaceutical company committed to discovering, developing and commercializing drugs to meet the needs of patients with severe bacterial and fungal infections. The Company has operating subsidiaries in the United Kingdom and Germany. Geographically company derives revenue from Japan, Ireland, Republic of Korea, USA, Uruguay, Sweden, Canada, Jordan, Switzerland and Other countries.

Address

Grenzacherstrasse 487

Basel
CHE
4005

Telephone

+41 616061233

Website

https://www.basilea.com

Sector

Healthcare

Forecast key dates

Name	Key Date

Previous key dates

Name	Key Date

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.